US74006W2070 - Common Stock
PRAXIS PRECISION MEDICINES I
NASDAQ:PRAX (5/1/2024, 7:17:17 PM)
After market: 55.16 0 (0%)55.16
+0.29 (+0.53%)
Praxis Precision Medicines Inc is a US-based company operating in Biotechnology industry. The company is headquartered in Boston, Massachusetts and currently employs 109 full-time employees. The company went IPO on 2020-10-16. Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company. The company is focused on translating insights from genetic epilepsies into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalances. The firm is applying genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms, using its understanding of shared biological targets and circuits in the brain. Its platform includes Cerebrum, a small molecule platform, which utilizes understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally precision therapies; and Solidus, is an antisense oligonucleotide (ASO) platform, which targets precision medicine discovery and development engine anchored on a proprietary, computational methodology. Its product candidates include PRAX-944, PRAX-562, PRAX-628 and PRAX-222.
PRAXIS PRECISION MEDICINES I
99 High Street, 30th Floor
Boston MASSACHUSETTS 02142
P: 16173008460
CEO: Marcio Souza
Employees: 109
Website: https://praxismedicines.com/
Innovative design of ongoing Phase 3 clinical program expected to set precedent for future clinical trials in essential tremor
Innovative design of ongoing Phase 3 clinical program expected to set precedent for future clinical trials in essential tremor...
BOSTON, April 05, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating...
BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a clinical-stage biopharmaceutical company translating...
Here you can normally see the latest stock twits on PRAX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: